| S.No. |
Title |
Source Title |
Authors |
DOI |
Citing Works Count |
| 1 |
Role of Nitric Oxide in Neurodegeneration: Function, Regulation, and Inhibition.
|
Current Neuropharmacology
|
Devesh Tewari; Archana N. Sah; Sweta Bawari; Seyed Fazel Nabavi; Ahmad Reza Dehpour; Samira Shirooie; Nady Braidy; Bernd L. Fiebich; Rosa Anna Vacca; Seyed Mohammad Nabavi
|
10.2174/1570159x18666200429001549
|
3
|
| 2 |
Applications of Machine Learning in miRNA Discovery and Target Prediction.
|
Current Genomics
|
Alisha Parveen; Syed Husain Mustafa; Pankaj Yadav; Abhishek Kumar
|
10.2174/1389202921666200106111813
|
5
|
| 3 |
Intracranial Aneurysms in Sickle Cell Disease.
|
Current Neurovascular Research
|
Ramazan Jabbarli; Thiemo Florin Dinger; Daniela Pierscianek; Marvin Darkwah Oppong; Bixia Chen; Philipp Dammann; Karsten H. Wrede; Klaus Kaier; Martin Köhrmann; Michael Forsting; Christoph Kleinschnitz; Ulrich Sure
|
10.2174/1567202616666190131160847
|
3
|
| 4 |
The Role of Mineralocorticoid Receptor Antagonists in Heart Failure with Reduced Ejection Fraction
|
Current Pharmaceutical Design
|
Vasilios Papademetriou; Maria Toumpourleka; Konstantinos Imprialos; Sofia Alataki; Alexandros Manafis; Konstantinos Stavropoulos
|
10.2174/1381612825666190219141326
|
3
|
| 5 |
Targeting Protective Catalase of Tumor Cells with Cold Atmospheric Plasma- Activated Medium (PAM)
|
Anti-cancer Agents In Medicinal Chemistry
|
Georg Bauer
|
10.2174/1871520617666170801103708
|
21
|
| 6 |
Optimizing Antitumor Efficacy and Adverse Effects of Pegylated Liposomal Doxorubicin by Scheduled Plasmapheresis: Impact of Timing and Dosing
|
Current Drug Delivery
|
Romeo Ngoune; Christine Contini; Michael M. Hoffmann; Dominik von Elverfeldt; Karl Winkler; Gerhard Pütz
|
10.2174/1567201815666180518125839
|
4
|
| 7 |
Metabolism of Nine Synthetic Cannabinoid Receptor Agonists Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MS.
|
Current Pharmaceutical Biotechnology
|
Melanie Hutter; Sebastian Broecker; Stefan Kneisel; Florian Franz; Simon D. Brandt; Volker Auwärter
|
10.2174/1389201019666180509163114
|
6
|
| 8 |
Determinants of Macromolecular Specificity from Proteomics-Derived Peptide Substrate Data
|
Current Protein & Peptide Science
|
Julian E. Fuchs; Oliver Schilling; Klaus R. Liedl
|
10.2174/1389203717666160724211231
|
0
|
| 9 |
Severe Drug Hypersensitivity Reactions: Clinical Pattern, Diagnosis, Etiology and Therapeutic Options
|
Current Pharmaceutical Design
|
Maren Paulmann; Maja Mockenhaupt
|
10.2174/1381612822666160928125152
|
17
|
| 10 |
Molecular Diagnosis in Autoimmune Skin Blistering Conditions
|
Current Molecular Medicine
|
J.V. Otten; Takashi Hashimoto; Michael Hertl; Aimee S. Payne; Cassian Sitaru
|
10.2174/15665240113136660079
|
68
|
| 11 |
Pimozide Inhibits the AcrAB-TolC Efflux Pump in Escherichia coli.
|
The Open Microbiology Journal
|
Jürgen A. Bohnert; Sabine Schuster; Winfried V. Kern
|
10.2174/1874285801307010083
|
14
|
| 12 |
Extraction, structure and bioactivities of the polysaccharides from Fructus corni.
|
Recent Patents On Food, Nutrition & Agriculture
|
Yanfang Wu; Xinsheng Wang; Biao Shen; Lei Kang; Enguo Fan
|
10.2174/2212798411305010009
|
15
|
| 13 |
Ethanol Production in Actinomycetes after Expression of Synthetic adhB and pdc
|
The Open Biotechnology Journal
|
Uwe Hardter; Marta Luzhetska; Sandra Ebeling; Andreas Bechthold
|
10.2174/1874070701206010013
|
4
|
| 14 |
New parenteral anticoagulants: focus on factor Xa and thrombin inhibitors.
|
Current Drug Discovery Technologies
|
Ingo Ahrens; Christoph Bode
|
10.2174/1570163811209020129
|
5
|
| 15 |
Immunotherapy for Malignant Melanoma Robert
|
Current Stem Cell Research & Therapy
|
Robert Zeiser; Marc Schnitzler; Hana Andrlová; Tina Hellige; Frank Meiss
|
10.2174/157488812799859883
|
14
|
| 16 |
Left Anterior Temporal Lobe Sustains Naming in Alzheimers Dementia and Mild Cognitive Impairment
|
Current Alzheimer Research
|
Lars Frings; Stefan Klöppel; Stefan J. Teipel; Oliver Peters; Lutz Frölich; Johannes Pantel; Johannes Schröder; Hermann-Josef Gertz; Sönke Arlt; Isabella Heuser; Johannes Kornhuber; Jens Wiltfang; Wolfgang Maier; Frank Jessen; Harald H
|
10.2174/156720511798192673
|
17
|
| 17 |
Perspectives on Sesquiterpene Lactones in Inflammation and Cancer
|
Current Drug Targets
|
Irmgard Merfort
|
10.2174/138945011798109437
|
188
|
| 18 |
Induction of Experimental Arthritis by Borrelial Lipoprotein and CpG Motifs: Are Toll-Like Receptors 2, 4, 9 or CD-14 Involved?
|
The Open Rheumatology Journal
|
Stephen Batsford; John J. Dunn; Michael J. Mihatsch
|
10.2174/1874312901105010018
|
3
|
| 19 |
Histomorphometric Evaluation of Anorganic Bovine Bone Coverage to Reduce Autogenous Grafts Resorption: Preliminary Results
|
The Open Dentistry Journal
|
Carlo Maiorana; Mario Beretta; Giovanni Battista Grossi; Franco Santoro; Alan S. Herford; Heiner Nagursky; Marco Cicciù
|
10.2174/1874210601105010071
|
44
|
| 20 |
Microglia Phenotype Diversity
|
CNS & Neurological Disorders Drug Targets
|
Marta Olah; Knut Biber; Jonathan Vinet; Hendrikus Boddeke
|
10.2174/187152711794488575
|
173
|
| 21 |
Respiratory syncytial virus bronchiolitis and asthma - insights from recent studies and implications for therapy.
|
Inflammation & Allergy Drug Targets
|
Beena Mailaparambil; Ruth Grychtol; Andrea Heinzmann
|
10.2174/187152809788681056
|
5
|
| 22 |
Targeted therapies for prostate cancer against the prostate specific membrane antigen.
|
Current Drug Targets
|
Ursula Elsässer-Beile; Patrick Bühler; Philipp Wolf
|
10.2174/138945009787354601
|
75
|
| 23 |
Assays for histone deacetylases.
|
Current Topics In Medicinal Chemistry
|
Alexander-Thomas Hauser; Mira Jung; Manfred Jung
|
10.2174/156802609788085269
|
13
|
| 24 |
Glycosyltransferases, Important Tools for Drug Design
|
Current Topics In Medicinal Chemistry
|
Andriy Luzhetskyy; Carmen Méndez; José A. Salas; Andreas Bechthold
|
10.2174/156802608784221514
|
65
|
| 25 |
Inhibitors of NAD+ Dependent Histone Deacetylases (Sirtuins)
|
Current Pharmaceutical Design
|
Manfred Jung; Robert C. Neugebauer; Wolfgang Sippl
|
10.2174/138161208783885380
|
70
|
| 26 |
Epigenetic lesions in malignant melanoma.
|
Current Pharmaceutical Biotechnology
|
Schwabe M; Lübbert M
|
10.2174/138920107783018372
|
26
|
| 27 |
Targeting RAS signaling pathways in juvenile myelomonocytic leukemia.
|
Current Drug Targets
|
Christian Flotho; Christian P. Kratz; Charlotte M. Niemeyer
|
10.2174/138945007780830773
|
39
|
| 28 |
From Interactions of Single Transmembrane Helices to Folding of α-Helical Membrane Proteins: Analyzing Transmembrane Helix-Helix Interactions in Bacteria
|
Current Protein & Peptide Science
|
Dirk Schneider; Carmen Finger; Alexander Prodöhl; Thomas Volkmer
|
10.2174/138920307779941578
|
42
|
| 29 |
Emerging roles of cysteine cathepsins in disease and their potential as drug targets.
|
Current Pharmaceutical Design
|
Olga Vasiljeva; Thomas Reinheckel; Christoph Peters; Dušan Turk; Vito Turk; Boris Turk
|
10.2174/138161207780162962
|
372
|
| 30 |
The role of NAD+ dependent histone deacetylases (sirtuins) in ageing.
|
Current Drug Targets
|
Johannes Trapp; Manfred Jung
|
10.2174/1389450110607011553
|
46
|
| 31 |
DNA hypermethylation of myeloid cells, a novel therapeutic target in MDS and AML.
|
Current Pharmaceutical Biotechnology
|
Claudia Müller; Björn Rüter; H. Phillip Koeffler; Michael Lübbert
|
10.2174/138920106778521523
|
49
|
| 32 |
Interactions of chemicals and metal ions with proteins and role for immune responses.
|
Mini Reviews In Medicinal Chemistry
|
Stefan F. Martin; Irmgard Merfort; Hermann-Josef Thierse
|
10.2174/138955706776073493
|
25
|
| 33 |
Telomeres, telomerase and malignant transformation.
|
Current Molecular Medicine
|
Oliver G. Opitz
|
10.2174/1566524053586626
|
30
|
| 34 |
Endothelin-1 and endothelin converting enzyme-1 in human atherosclerosis--novel targets for pharmacotherapy in atherosclerosis.
|
Current Vascular Pharmacology
|
Christian Ihling; B. Bohrmann; H. E. Schaefer; K. Technau-Ihling; B. M. Loeffler
|
10.2174/1570161043385718
|
25
|
| 35 |
Application of non-covalently solid-phase bound catalysts.
|
Combinatorial Chemistry & High Throughput Screening
|
Florian Michalek; Joachim Horn; C. Christoph Tzschucke; Willi Bannwarth
|
10.2174/138620703771981250
|
2
|
| 36 |
Regulation of eosinophil migration and Th2 cell function by IL-5 and eotaxin.
|
Current Drug Targets. Inflammation And Allergy
|
Joerg Mattes; Paul S. Foster
|
10.2174/1568010033484214
|
50
|
| 37 |
Innate T-Cell Immunity in HIV Infections: The Role of Vg9Vd2 T Lymphocytes
|
Current Molecular Medicine
|
Fabrizio Poccia; Marie-Lise Gougeon; Chiara Agrati; Camilla Montesano; F. Martini; C. D. Pauza; Paul Fisch; Marianne Wallace; Miroslav Malkovsky
|
10.2174/1566524023361880
|
34
|
| 38 |
Pathways of inflammatory activation in Alzheimer's disease: potential targets for disease modifying drugs.
|
Current Medicinal Chemistry
|
Michael Hüll; Klaus Lieb; Bernd L. Fiebich
|
10.2174/0929867023371292
|
78
|
| 39 |
Instructions from the vascular system - directing neural stem cell fate in health and disease.
|
Current Medicinal Chemistry
|
Sebastian Schildge; Christian Bohrer; Sabrina Pfurr; Könül Mammadzada; Kristina Schachtrup; Christian Schachtrup
|
10.2174/0929867321666131227162215
|
6
|
